MiRNAs and lncRNAs in NK cell biology and NK/T-cell lymphoma

FengXia Gao; SiRong He; AiShun Jin

doi:10.1016/j.gendis.2020.08.006

您当前的位置：

首页 >

文章列表页 >

MiRNAs and lncRNAs in NK cell biology and NK/T-cell lymphoma

更新时间：2022-06-24

- MiRNAs and lncRNAs in NK cell biology and NK/T-cell lymphoma
- Genes & Diseases Vol. 8, Issue 5, (2021)
- 作者机构：
  
  1. Department of Immunology, Chongqing Medical University,Chongqing,PR China,400010
  2. Chongqing Key Laboratory of Tumor Immunology and Tumor Immunotherapy, Chongqing Medical University, No.1, Medical School Road, Yuzhong District,Chongqing,PR China,400010
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2020.08.006
  CLC：
- Published：2021，
  
  Published Online：1 September 2021，
扫描看全文
FengXia Gao, SiRong He, AiShun Jin. MiRNAs and lncRNAs in NK cell biology and NK/T-cell lymphoma. [J]. Genes & Diseases 8(5).(2021)
DOI：

FengXia Gao, SiRong He, AiShun Jin. MiRNAs and lncRNAs in NK cell biology and NK/T-cell lymphoma. [J]. Genes & Diseases 8(5).(2021) DOI： 10.1016/j.gendis.2020.08.006.

摘要

Abstract

The important role of lncRNAs and miRNAs in directing immune responses has become increasingly clear. Recent evidence conforms that miRNAs and lncRNAs are involved in NK cell biology and diseases through RNA–protein

RNA–RNA

or RNA–DNA interactions. In this view

we summarize the contribution of miRNAs and lncRNAs to NK cell lineage development

activation and function

highlight the biological significance of functional miRNAs or lncRNAs in NKTL and discuss the potential of these miRNAs and lncRNAs as innovative biomarkers/targets for NKTL early diagnosis

target treatment and prognostic evaluations.

关键词

Keywords

ActivationDevelopmentFunctionlncRNAsmiRNANK cell BiologyNK/T-cell lymphoma

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

The Wnt-dependent and Wnt-independent functions of BCL9 in development, tumorigenesis, and immunity: Implications in therapeutic opportunities

Breaking paradigms: Long non-coding RNAs forming gene fusions with potential implications in cancer

Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer

Structure, ligands, and roles of GPR126/ADGRG6 in the development and diseases

New insights into the roles for DYRK family in mammalian development and congenital diseases

Related Author

Minjie Wu

Heng Dong

Chao Xu

Mengqing Sun

Haojin Gao

Fangtian Bu

Jianxiang Chen

David Sánchez-Marín

Related Institution

Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University

Laboratory of Cancer Genomics, Division of Cellular and Molecular Research, National Cancer Centre

College of Pharmacy and Department of Hepatology, Institute of Hepatology and Metabolic Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University

Unidad Académica Multidisciplinaria Región Altiplano, Universidad Autónoma de San Luis Potosí (UASLP), Carretera a Cedral Km 5+600, Ejido San José de la Trojes, Matehuala, San Luis Potosí, C.P. 78760, México

Servicio de Anatomía Patológica, Instituto Nacional de Cancerología (INCan), Niño Jesús, Tlalpan, Ciudad de México, C.P. 14080, México

⁰